Literature DB >> 10531278

Chlamydia trachomatis (mouse pneumonitis strain) induces cardiovascular pathology following respiratory tract infection.

Y Fan1, S Wang, X Yang.   

Abstract

Chlamydia, especially Chlamydia pneumoniae, infection is closely associated with human cardiovascular diseases. Thus far, however, few experimental studies have been carried out to investigate whether natural C. trachomatis infection can induce cardiovascular pathological changes. In this article, we report that pulmonary infection with C. trachomatis mouse pneumonitis strain (MoPn) can induce myocardial and perivascular inflammation and fibrosis in C57BL/6 mice. The pulmonary MoPn infection appeared to be disseminated systemically, because chlamydial antigens were readily detectable in multiple organs including the cardiovascular tissues. In addition, gamma interferon gene knockout mice with a C57BL/6 genetic background showed significant endocarditis and pancarditis characterized by vegetation in aortic valves, interstitial and pericardial inflammatory cellular infiltration, and growth of the organisms in the heart following respiratory tract MoPn infection. The results indicate that C. trachomatis can induce cardiovascular diseases following respiratory tract infection and suggest that murine MoPn respiratory tract infection may be a useful experimental model for investigating cardiovascular diseases caused by chlamydial infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531278      PMCID: PMC97004     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis--an update.

Authors:  P Saikku
Journal:  Scand J Infect Dis Suppl       Date:  1997

2.  Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction.

Authors:  M Leinonen; E Linnanmäki; K Mattila; M S Nieminen; V Valtonen; M Leirisalo-Repo; P Saikku
Journal:  Microb Pathog       Date:  1990-07       Impact factor: 3.738

3.  Chlamydia linked to atherosclerosis.

Authors:  C Mlot
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

4.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

5.  [Osler's endocarditis possibly caused by Chlamydia pneumoniae (TWAR stain)].

Authors:  D Dumont; D Mathieu; M Alemanni; F Eb; G Manigand
Journal:  Presse Med       Date:  1990-06-02       Impact factor: 1.228

6.  Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice.

Authors:  T W Cotter; K H Ramsey; G S Miranpuri; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection.

Authors:  X Yang; K T HayGlass; R C Brunham
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

8.  Role of Chlamydia trachomatis in perinatal infection.

Authors:  E R Alexander; H R Harrison
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

9.  Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls.

Authors:  R L Bailey; M J Holland; H C Whittle; D C Mabey
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in vivo.

Authors:  G M Zhong; E M Peterson; C W Czarniecki; L M de la Maza
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more
  6 in total

1.  Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice.

Authors:  E Blessing; T M Lin; L A Campbell; M E Rosenfeld; D Lloyd; C Kuo
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

2.  Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae.

Authors:  J Rödel; M Woytas; A Groh; K H Schmidt; M Hartmann; M Lehmann; E Straube
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice.

Authors:  E Blessing; S Nagano; L A Campbell; M E Rosenfeld; C C Kuo
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Reemergence of the Murine Bacterial Pathogen Chlamydia muridarum in Research Mouse Colonies.

Authors:  Noah Mishkin; Rodolfo J Ricart Arbona; Sebastian E Carrasco; Samira Lawton; Kenneth S Henderson; Panagiota Momtsios; Ira M Sigar; Kyle H Ramsey; Christopher Cheleuitte-Nieves; Sebastien Monette; Neil S Lipman
Journal:  Comp Med       Date:  2022-07-08       Impact factor: 1.565

Review 5.  Relevance of molecular mimicry in the mediation of infectious myocarditis.

Authors:  Chandirasegaran Massilamany; Sally A Huber; Madeleine W Cunningham; Jay Reddy
Journal:  J Cardiovasc Transl Res       Date:  2013-11-22       Impact factor: 4.132

6.  Association of Chlamydia trachomatis, C. pneumoniae, and IL-6 and IL-8 Gene Alterations With Heart Diseases.

Authors:  Nubia Caroline Costa Almeida; Maria Alice Freitas Queiroz; Sandra Souza Lima; Igor Brasil Costa; Marco Antonio Ayin Fossa; Antonio Carlos R Vallinoto; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Front Immunol       Date:  2019-02-05       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.